NEUCA S.A. (FRA:7HD)

Market Cap	733.46M -3.2%
Revenue (ttm)	3.23B +8.2%
Net Income	36.87M +0.9%
EPS	8.07 +0.1%
Shares Out	n/a
PE Ratio	19.89
Forward PE	15.70
Dividend	3.76 (2.34%)
Ex-Dividend Date	Jul 15, 2025

Volume	n/a
Average Volume	n/a
Open	161.00
Previous Close	157.00
Day's Range	161.00 - 161.00
52-Week Range	147.80 - 199.80
Beta	n/a
RSI	45.37
Earnings Date	Mar 26, 2026

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1990
• Employees: 4,445
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7HD

Financial Performance

In 2025, NEUCA's revenue was 13.64 billion, an increase of 8.18% compared to the previous year's 12.61 billion. Earnings were 155.58 million, an increase of 0.87%.

Financial numbers in PLN